Clinical trial
Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic…
NCT00388362 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00388362 |
|---|---|
| Title | Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease |
| Official title | A Phase II Trial of Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft vs Host Disease |
| Intervention type | Drug |
| Interventions | Sirolimus, Prednisone |
| Enrollment | 36 |
| Start date | Nov 1, 2005 |
| Primary completion | Nov 1, 2010 |
| Completion | Aug 1, 2012 |
| First posted | Oct 16, 2006 |
| Last update posted | Apr 21, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: